Eisai

4523.TSE

33.17 USD

0.45

+1.38%

Overview

Last close

33.17 usd

Market cap

9.35B usd

52 week high

42.10 usd

52 week low

24.09 usd

Target price

31.93 usd

Valuation

P/E

28.84

Forward P/E

32.6797

Price/Sales

1.7604

Price/Book Value

1.5837

Enterprise Value

8.58B usd

EV/Revenue

1.6403

EV/EBITDA

11.9875

Key financials

Revenue TTM

5.26B usd

Gross Profit TTM

4.09B usd

EBITDA TTM

579.00M usd

Earnings per Share

1.14 usd

Dividend

1.04 usd

Total assets

9.49B usd

Net debt

-564.15M usd

About

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals. It also offers prescription medicines. In addition, the company focuses on neurology and oncology and therapeutic areas. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.